Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-12

Clinical Trial Update: Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral salmon calcitonin for knee osteoarthritis has been terminated with posted results in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Salmon Calcitonin (salmon calcitonin)

Snippet

Sponsor: Nordic Bioscience A/S | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2012-09-12